Production

Engineering and non quality costs process equipment as part of the production of a new vaccine

 
 
 
 
1
1

Rhône (69) FRANCE

4 years - 2018 to 2022

€70 million

Project DNA

  • Production of a new vaccine to replace two commercially available vaccines
  • Construction of 2 extensions on one building to allow the installation of 2 vaccine production lines in the existing building producing two other vaccines;
  • Implementation of the validated process with the same biocomparability;
  • Completion of the bulk validation batch manufacturing at the end of 2022 and launch of the vaccine in 2026.

Expertise

  • USP, DSP and cross-functional equipment

PHARMACOS service

  • Engineering studies and execution up to the Commissioning and Qualification of batches:
    Cell culture and viral culture,
    Gross harvest and clarification
    CIP Station

Challenges

Economic

100%

Environmental

20%

Marketing

60%

Biosafety

60%

Regulatory

60%

CONTACTEZ-NOUS

et parlez-nous de votre projet

PHARMACOS
CONSULTANCY

Agence ARA
Z.A.C. de Sacuny
440 rue Barthélémy Thimonnier
69530 Brignais – France

Agence IDF-Normandie
43 rue Pierre Brossolette
92300 Levallois-Perret - France

Agence Centre-Val de Loire
CM101 – Cité de l’innovation
36 rue des Bellangères – Bâtiment 23
28630 Le Coudray – France

Tél. +33 (0)4 37 57 78 78

PHARMACOS
CONSULTANCY

Agence ARA
Z.A.C. de Sacuny
440 rue Barthélémy Thimonnier
69530 Brignais – France

Agence IDF-Normandie
43 rue Pierre Brossolette
92300 Levallois-Perret - France

Agence Centre-Val de Loire
CM101 – Cité de l’innovation
36 rue des Bellangères – Bâtiment 23
28630 Le Coudray – France

Tél. +33 (0)4 37 57 78 78

  • This field is for validation purposes and should be left unchanged.

JOB DATING

Envie d’un nouveau challenge ? Rejoignez-nous !

CANDIDATER